← 返回前沿论文

肝脾 T 细胞淋巴瘤:诊断难题

英文原题:Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum.

PubMed 2022/01/01(内容时间) Int J Hematol Oncol Stem Cell Res

研究概要

肝脾T细胞淋巴瘤(HSTCL)是一种非常罕见且侵袭性强的外周T细胞淋巴瘤,占非霍奇金淋巴瘤(NHL)的比例不到1%。

中文摘要

肝脾T细胞淋巴瘤(HSTCL)是一种非常罕见且侵袭性的外周T细胞淋巴瘤,占非霍奇金淋巴瘤(NHL)的不到1%。它来源于细胞毒性T细胞,通常为γδ T细胞受体类型,其特征为原发性结外病变,典型表现为中等大小淋巴细胞对肝脏、脾脏和骨髓的窦状浸润。HSTCL更常见于免疫功能低下患者,尤其是接受长期免疫抑制治疗者。其鉴别诊断多样,临床病程凶险,对目前可用治疗反应差。本文报告一例20岁免疫功能正常男性HSTCL患者,表现为发热、苍白、体重下降、双系血细胞减少、肝大和巨脾,突出诊断困境及指向准确诊断的线索。诊断的关键在于骨髓中非典型淋巴细胞的形态学发现、流式细胞术的典型免疫表型特征以及肝脏和脾脏的受累模式,即使在缺乏完整诊断组合和工具的情况下也是如此。本病例报告旨在强调对此类罕见疾病保持高度警惕以及时发现。

展开英文摘要原文

Hepatosplenic T cell lymphoma (HSTCL) is a very rare and aggressive peripheral T cell lymphoma that comprises less than 1% of Non-Hodgkin lymphomas (NHL). It is derived from cytotoxic T-cells, usually of γδ T cell receptor type, and is characterized by primary extranodal disease with typical sinusoidal infiltration of the liver, spleen and bone marrow by medium-sized lymphoid cells. HSTCL occurs more frequently in immunocompromised patients, especially in those receiving long-term immunosuppressive therapy. The differential diagnosis is varied, and the clinical course is dismal with a poor response to currently available therapies. Herein we report a case of HSTCL in a 20-year-old immunocompetent male who presented with fever, pallor, weight loss, bicytopenia, hepatomegaly, and massive splenomegaly, highlighting the diagnostic conundrum and pointers towards an accurate diagnosis. The key role for diagnosis was the combination of morphologic finding of atypical lymphoid cells in the bone marrow, typical immunophenotypic profile on flow cytometry and the pattern of involvement of the liver and the spleen, even in the absence of full-fledged diagnostic panels and tools. The report of this case is an endeavor to emphasize the high index of suspicion for timely detection of such a rare entity.

论文信息

作者
Chowdhury Z、Khonglah Y、Raphael V、Kalita P、Das U
第一作者单位
Department of Pathology, Homi Bhabha Cancer Hospital/MPMMCC (TATA Memorial Hospital), Varanasi, Uttar Pradesh, India.India
通讯作者单位
Department of Pathology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong, Meghalaya, India.India
文献类型
病例报告
期刊
International journal of hematology-oncology and stem cell research2022 Jan 1
原文标识
PubMed 35975114 · DOI 10.18502/ijhoscr.v16i1.8444